| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of 1 Medicine and 2 Physiology, Banting and Best Diabetes Centre, Toronto Hospital, University of Toronto, Toronto, Ontario, Canada M5G 2C4
The control of intestinal epithelial growth is regulated by interactions of growth factors in various cellular compartments of the small and large bowel. Little information is available on the intestinal growth response to combinations of growth factors. We studied the intestinotrophic properties of a dipeptidyl peptidase IV resistant glucagon-like peptide 2 (GLP-2) analog, human [Gly2]GLP-2 (h[Gly2]GLP-2), as well as of epidermal growth factor (EGF), long [Arg3]insulin-like growth factor I (LR3IGF-I), [Gly1]IGF-II, and human growth hormone (hGH), administered by subcutaneous injection alone or in combination in mice. At the doses tested, h[Gly2]GLP-2 was the most potent agent for increasing small and large bowel mass. Mice treated with h[Gly2]GLP-2 and either GH or IGF-I exhibited greater increases in histological parameters of small intestinal growth than did mice treated with h[Gly2]GLP-2 alone. Administration of all five growth factors together induced significant increases in crypt plus villus height and in small and large bowel length and weight. The results of these experiments define regional differences in both the cellular targets and relative activities of intestinotrophic molecules and raise the possibility that selective growth factor combinations may be useful for enhancement of intestinal adaptation in vivo.
protein; bowel; gut; adaptation; mouse
This article has been cited by other articles:
|
|
 |
|
  D. L. Sigalet, L. E. Wallace, J. J. Holst, G. R. Martin, T. Kaji, H. Tanaka, and K. A. Sharkey Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2 Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G211 - G221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. Martin, L. E. Wallace, and D. L. Sigalet Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome Am J Physiol Gastrointest Liver Physiol, June 1, 2004; 286(6): G964 - G972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Aubin-Houzelstein, N. R. Da Silva, S. Bellier, P. Salaun, X. Montagutelli, and J.-J. Panthier Genetic interaction between a maternal factor and the zygotic genome controls the intestine length in PRM/Alf mice Physiol Genomics, December 16, 2003; 16(1): 82 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Mayo, L. J. Miller, D. Bataille, S. Dalle, B. Goke, B. Thorens, and D. J. Drucker International Union of Pharmacology. XXXV. The Glucagon Receptor Family Pharmacol. Rev., March 1, 2003; 55(1): 167 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Li, T. Hansotia, B. Yusta, F. Ris, P. A. Halban, and D. J. Drucker Glucagon-like Peptide-1 Receptor Signaling Modulates beta Cell Apoptosis J. Biol. Chem., January 3, 2003; 278(1): 471 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D J Drucker Gut adaptation and the glucagon-like peptides Gut, March 1, 2002; 50(3): 428 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Kitchen, A. J. Fitzgerald, R. A. Goodlad, N. F. Barley, M. A. Ghatei, S. Legon, S. R. Bloom, A. Price, J. R. F. Walters, and A. Forbes Glucagon-like peptide-2 increases sucrase-isomaltase but not caudal-related homeobox protein-2 gene expression Am J Physiol Gastrointest Liver Physiol, March 1, 2000; 278(3): G425 - G428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Boushey, B. Yusta, and D. J. Drucker Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E937 - E947. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Munroe, A. K. Gupta, F. Kooshesh, T. B. Vyas, G. Rizkalla, H. Wang, L. Demchyshyn, Z.-J. Yang, R. K. Kamboj, H. Chen, et al. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2 PNAS, February 16, 1999; 96(4): 1569 - 1573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Drucker, B. Yusta, R. P. Boushey, L. DeForest, and P. L. Brubaker Human [Gly2]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis Am J Physiol Gastrointest Liver Physiol, January 1, 1999; 276(1): G79 - G91. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Scott, D. Kirk, W. K. MacNaughton, and J. B. Meddings GLP-2 augments the adaptive response to massive intestinal resection in rat Am J Physiol Gastrointest Liver Physiol, November 1, 1998; 275(5): G911 - G921. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
